Meeting Archive:
Neonatal Abstinence Syndrome (NAS) Definition, Coding and Report


Meeting Description:

Increased use of opioids by pregnant women is resulting in an increase of babies born with neonatal abstinence syndrome (NAS). While the incidence of NAS varies by regions of the state, hospitals in Florida are seeing significant growth in the number of babies born exposed to opioids or illicit drugs during the prenatal period. In 2017, an estimated 1.700 babies were born in Florida diagnosed with NAS. Decreasing the number of newborns experiencing NAS is a goal under the Florida State Health Improvement Plan and is a priority of the Florida Medicaid Program, with Medicaid managed care organizations charged with reducing the number of Medicaid funded NAS babies by 15 percent.

FHA has partnered with Florida Perinatal Quality Collaborative (FPQC) to provide this educational opportunity on ensuring accurate identfication, ICD10 coding and reporting on NAS.

FPQC, which focuses on improving maternal and infant health and health care, has developed a comprehensive toolkit, useful online resources and other evidence-based practices/materials for treating infants exhibiting post-natal signs of withdrawal due to chronic in utero exposure to opioids.

Who should attend: Maternal/Child Health Directors, NICU Directors, Chief Nursing Officers, Chief Medical Officers, Education Specialists, Case Managers/Discharge Planners and Quality Improvement Teams.
Details
Date: Wed, Feb 20, 2019
Time: 12:30 PM EST
Duration: 30 minutes
Host(s): Kim Streit, FHA
 Presenter Information
Florida Hospital Association
Speaker Photo

Kim Streit, FACHE, MBA, MHS
VP, Healthcare Research and Information
kims@fha.org | 407-841-6230 (phone)

Florida Perinatal Quality Collaborative
Speaker Photo

William M. Sappenfield, MD, MPH, CPH
Professor, College of Public Health
Director, Florida Perinatal Quality Collaborative
wsappenf@health.usf.edu |813-974-3746 (phone)